Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.60
0.04 (2.56%)
At close: Aug 18, 2025, 3:59 PM
1.62
1.25%
Pre-market: Aug 19, 2025, 04:11 AM EDT

Pulmonx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
90.55M 87.47M 83.79M 79.3M 76.58M 72.99M 68.67M 64.82M 60.66M 57.41M 53.66M 51.95M 51.7M 49.96M 48.42M 44.54M 41.89M 33.36M
Cost of Revenue
24.29M 23.11M 21.79M 20.69M 19.97M 18.95M 18.02M 17.29M 16M 15.07M 13.8M 13.01M 13.19M 12.83M 12.79M 12.08M 11.71M 11.2M
Gross Profit
66.26M 64.36M 62M 58.61M 56.61M 54.04M 50.65M 47.54M 44.66M 42.34M 39.87M 38.93M 38.52M 37.13M 35.63M 32.46M 30.18M 22.16M
Operating Income
-58.63M -57.73M -57.7M -56.49M -57.54M -60.07M -61.93M -62.64M -61.4M -59.37M -58.64M -56.38M -52.21M -49.89M -46.25M -43.24M -38.83M -38.26M
Interest Income
3.9M 4.48M 5.06M 5.56M 5.78M 5.88M 5.57M 4.78M 3.76M 2.55M 1.53M 875K 497K 400K 400K 421K 331K 244K
Pretax Income
-56.4M -56.64M -55.89M -56.4M -57.29M -58.1M -60.27M -60.67M -60M -58.55M -58.57M -57.39M -53.35M -51.05M -47.27M -43.69M -37.36M -36.92M
Net Income
-56.94M -57.09M -56.39M -57.11M -57.86M -58.73M -60.84M -61.24M -60.13M -58.57M -58.54M -57.26M -53.66M -51.39M -47.61M -43.9M -37.58M -37.11M
Selling & General & Admin
105.37M 103.98M 102.14M 99.35M 97.93M 96.08M 94.51M 92.09M 87.82M 85.6M 83.11M 80.11M 77.08M 73.46M 68.82M 63.87M 58M 51.49M
Research & Development
19.52M 18.12M 17.57M 15.75M 16.22M 18.04M 18.08M 18.09M 18.23M 16.12M 15.4M 15.2M 13.65M 13.56M 13.06M 11.83M 11.01M 8.93M
Other Expenses
n/a -35K -35K -35K -297K -424K -316K -115K 147K 144K 36K -165K -165K -96K 65K 65K 65K 161K
Operating Expenses
124.89M 122.1M 119.7M 115.1M 114.15M 114.11M 112.59M 110.18M 106.06M 101.71M 98.5M 95.31M 90.73M 87.02M 81.88M 75.7M 69.01M 60.42M
Interest Expense
153K 3.4M 3.51M 3.57M 3.57M 3.54M 3.23M 2.69M 2.08M 1.44M 1.07M 906K 827K 810K 829K 897K 1.79M 2.5M
Selling & Marketing Expenses
n/a n/a n/a 4.8M 4.8M 4.8M 4.8M 6.1M 6.1M 6.1M 6.1M 5.1M 5.1M 5.1M 5.1M 3.15M 3.15M 3.15M
Cost & Expenses
149.18M 145.2M 141.49M 135.79M 134.12M 133.06M 130.61M 127.46M 122.05M 116.78M 112.3M 108.32M 103.91M 99.85M 94.67M 87.78M 80.72M 71.61M
Income Tax Expense
542K 449K 500K 710K 577K 633K 571K 569K 127K 27K -30K -124K 303K 343K 343K 212K 217K 193K
Shares Outstanding (Basic)
40.19M 39.95M 39.11M 39.28M 38.94M 38.64M 38.38M 38.12M 37.82M 37.57M 37.38M 37.19M 37M 36.81M 36.64M 36.45M 36.04M 35.37M
Shares Outstanding (Diluted)
40.19M 39.95M 39.11M 39.28M 38.94M 38.64M 38.38M 38.12M 37.82M 37.57M 37.38M 37.19M 37M 36.81M 36.64M 36.45M 36.04M 35.37M
EPS (Basic)
-1.43 -1.44 -1.44 -1.47 -1.5 -1.54 -1.6 -1.62 -1.6 -1.57 -1.58 -1.55 -1.46 -1.4 -1.31 -1.23 -1.06 -1.11
EPS (Diluted)
-1.43 -1.44 -1.44 -1.47 -1.5 -1.54 -1.6 -1.62 -1.6 -1.57 -1.58 -1.55 -1.46 -1.4 -1.31 -1.23 -1.06 -1.11
EBITDA
-64.05M -60.11M -57.7M -51.14M -51.99M -52.15M -54.07M -54.48M -54.45M -54.34M -55.47M -54.46M -50.68M -48.78M -45.61M -42.81M -35.67M -34.4M
EBIT
-61.66M -61.81M -59.4M -52.83M -53.71M -54.55M -57.04M -57.98M -57.92M -57.11M -57.5M -56.48M -52.52M -50.82M -47.49M -43.84M -36.62M -34.89M
Depreciation & Amortization
570K 1.5M 1.49M 1.69M 1.73M 2.4M 2.97M 3.5M 4.1M 4.01M 3.9M 3.88M 3.78M 3.57M 3.36M 2.59M 1.8M 1.14M